BioNTech (United States)

BioNTech (United States)

BioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for BioNTech (United States), United States, covering academic research published from 2000 to 2025. Read More.


Open Access Percentage

66%


Total
Publications

233


Total Open
Publications

153


Total
Citations

7.4K


Open Access
Percentage

66%


Total
Publications

233


Total Open
Publications

153


Total
Citations

7.4K

Wikipedia

Website

download

Breakdown

19% 26% 20% 35%

Publisher Open

19%

Both

26%

Other Platform Open

20%

Closed

35%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
20002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0510152025303540455055Total Publications
20002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025

Open

Closed

Publisher Open

49%OA Journal

OA Journal 49%

50

Hybrid 23%

24

No Guarantees 28%

29

Other Platform Open

Domain 54%

57

Institution 36%

38

Preprint 35%

37

Other Internet 4%

4

Public 1%

1

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
59
doaj.org OAI-PMH Repository
Institution
33
bioRxiv
Preprint
18
Research Square
Preprint
8
medRxiv
Preprint
7
DOI
Other Internet
4
ChemRxiv
Preprint
4
Europe PMC
Domain
2
Aalborg University
Institution
2
University of Copenhagen
Institution
1
1 / 2

Data updated 18 June 2026

Share

Share

Share